The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Inspire Medical Systems Inc shares valued at $259,025 were sold by Rondoni John on May 19 ’25. At $149.38 per share, Rondoni John sold 1,734 shares. The insider’s holdings dropped to 13,766 shares worth approximately $1.9 million following the completion of this transaction.
Also, JOHN RONDONI purchased 1,734 shares, netting a total of over 259,025 in proceeds.
Before that, mcCormick Shawn had sold 360 shares from its account. In a trade valued at $57,600, the Director traded Inspire Medical Systems Inc shares for $160.00 each. Upon closing the transaction, the insider’s holdings decreased to 360 shares, worth approximately $3.32 million.
As published in a research note from BofA Securities on November 20, 2024, Inspire Medical Systems Inc [INSP] has been rated up from a Neutral to a Buy and the price target has been revised to $255 from $220. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early May. As of April 19, 2024, RBC Capital Mkts has initiated its “an Outperform” rating for INSP. Earlier on March 19, 2024, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for INSP stock.
Analyzing INSP Stock Performance
During the last five days, there has been a drop of approximately -5.37%. Over the course of the year, Inspire Medical Systems Inc shares have dropped approximately -25.42%. Shares of the company reached a 52-week high of $216.01 on 01/07/25 and a 52-week low of $132.69 on 04/07/25.
Support And Resistance Levels for Inspire Medical Systems Inc (INSP)
According to the 24-hour chart, there is a support level at 134.81, which, if violated, would cause prices to drop to 131.38. In the upper region, resistance lies at 142.39. The next price resistance is at 146.54. RSI (Relative Strength Index) is 33.42 on the 14-day chart, showing neutral technical sentiment.
